Examkin

Question

Difficulty: HardGynecologic Oncology

An 18-year-old college student presents to the emergency department complaining of progressive pelvic heaviness and a sudden exacerbation of sharp right lower abdominal pain that began 12 hours ago. A transabdominal ultrasound demonstrates a 14-cm complex right ovarian mass featuring prominent solid components. Her urine pregnancy test is negative. Arrange the following interventions in the most appropriate chronological sequence for the standard diagnostic workup and definitive management of this patient.

  1. 1Draw serum for quantitative beta-hCG, alpha-fetoprotein (AFP), and lactate dehydrogenase (LDH)
  2. 2Perform a unilateral salpingo-oophorectomy and send the excised specimen for intraoperative frozen section analysis
  3. 3Obtain peritoneal washings, perform an omentectomy, and sample pelvic and para-aortic lymph nodes
  4. 4Review the final permanent histopathology report to confirm the exact tumor subtype and FIGO stage
  5. 5Initiate multi-agent adjuvant systemic therapy with bleomycin, etoposide, and cisplatin (BEP)

Answer

The correct chronological sequence is: 1) Draw serum tumor markers, 2) Perform unilateral salpingo-oophorectomy with intraoperative frozen section, 3) Complete surgical staging if malignant, 4) Review final permanent histopathology, and 5) Initiate adjuvant BEP chemotherapy.
The standard of care for a young female with a suspicious complex adnexal mass prioritizes both fertility preservation and accurate oncologic staging. Preoperative tumor markers (AFP, LDH, hCG) are an essential first step for diagnosis and establishing a baseline for future surveillance. Surgery must begin with a fertility-sparing unilateral salpingo-oophorectomy and an immediate intraoperative frozen section. If malignancy is confirmed, the surgeon proceeds immediately to comprehensive staging (washings, omental biopsy, lymph node sampling) during the same operation to avoid a second surgery. Postoperatively, the final permanent pathology dictates the adjuvant plan, which typically consists of multi-agent BEP chemotherapy for malignant germ cell tumors.

Step-by-Step Solution

1
Obtain serum tumor markers (AFP, LDH, hCG).
Establishes a biochemical baseline prior to surgical manipulation.
Crucial for diagnosing specific germ cell tumors in young women and providing an indispensable baseline for monitoring therapeutic response and disease recurrence.
2
Perform unilateral salpingo-oophorectomy and obtain a frozen section.
Safely removes the primary tumor while preserving the contralateral ovary and uterus.
Fertility preservation is paramount in young patients. The intraoperative frozen section dictates whether the surgeon must proceed to more extensive staging procedures.
3
Complete comprehensive surgical staging.
Obtains peritoneal fluid, omental tissue, and lymph nodes for microscopic evaluation.
Required to determine the anatomical spread of the disease (FIGO stage) only if the intraoperative frozen section confirms a malignancy.
4
Review final permanent pathology.
Provides the precise histological subtype and formal formal surgical stage.
Permanent sections overcome the limitations of frozen sections (e.g., identifying mixed germ cell components) and definitively guide the necessity for adjuvant treatment.
5
Administer adjuvant BEP chemotherapy.
Eradicates microscopic residual disease.
Germ cell tumors are highly chemosensitive, and multi-agent chemotherapy is the standard of care following surgery to ensure long-term survival and cure in advanced or aggressive subtypes.

Key Concept

Management sequence of suspected ovarian germ cell tumors prioritizes preoperative tumor markers, fertility-sparing surgery with intraoperative frozen section, immediate surgical staging if malignant, and tailored adjuvant chemotherapy.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic